Skip to main content
SpringerLink
Log in

Störungen der Neurotransmission als Grundlage psychiatrischer Erkrankungen

  • Chapter
Psychiatrie und Psychotherapie

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Benjamin J, Ebstein RB, Lesch KP (1998) Genes for personality traits: implications for psychopathology. Int J Neuropsychopharmacol 1:153–158

    Article  PubMed  Google Scholar 

  • Benkert O, Hippius H (1996) Psychiatrische Pharmakotherapie. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Birkmayer W, Riederer P (1986) Neurotransmitter und menschliches Verhalten. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Birkmayer W, Danielczyk W, Neumayer E, Riederer P (1972) The balance of biogenic amines as condition for normal behaviour. J Neural Transm 33:163–178

    Article  CAS  PubMed  Google Scholar 

  • Bleich S, Bleich K, Wiltfang J, Maler JM, Kornhuber J (2001) Glutamaterge Neurotransmission bei Schizophrenien. Fortschr Neurol Psychiatr 69(Suppl 2):556–561

    Google Scholar 

  • Blokland A (1995) Acetylcholine: A neurotransmitter for learning and memory? Brain Res Brain Res Rev 21:285–300

    Article  CAS  PubMed  Google Scholar 

  • Carlsson A (1995) Neurocircuitries and neurotransmitter interactions in schizophrenia. Int Clin Psychopharmacol 10(Suppl 3):21–28

    PubMed  Google Scholar 

  • Carlsson A, Waters N, Holm-Waters S, Tedroff J, Wilsson M, Carlsson ML (2001) Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Ann Rev Pharmacol Toxicol 41:237–260

    CAS  Google Scholar 

  • Cloninger CR, Svrakic DM, Przybeck TR (1993) A psychobiological model of temperament and character. Arch Gen Psychiat 50:975–990

    CAS  PubMed  Google Scholar 

  • Coppen AJ (1967) The biochemistry of affective disorders. Br J Psychiatry 113:1237–1243

    CAS  PubMed  Google Scholar 

  • Edwards E, Kornrich W, van-Houtten P, Henn FA (1992) In vitro neurotransmitter release in an animal model of depression. Neurochem Int 21:29–35

    Article  CAS  PubMed  Google Scholar 

  • Flory JD, Manuck SB, Ferrell RE, Dent KM, Peters DG, Muldoon MF (1999) Neuroticism is not associated with the serotonin transporter (5-HTTLPR) polymorphism. Mol Psychiatry 4:93–96

    Article  CAS  PubMed  Google Scholar 

  • Fritze J, Deckert J, Lanczik M, Strik W, Struck M, Wodarz N (1992) Stand der Amin-Hypothese Depressiver Erkrankungen. Nervenarzt 63:3–13

    CAS  PubMed  Google Scholar 

  • Hattori M, Kunugi H, Akahane A et al. (2002) Novel polymorphisms in the promoter region of the neurotrophin-3 gene and their associations with schizophrenia. Am J Med Genet 114:304–309

    PubMed  Google Scholar 

  • Hsiao JK, Colison J, Bartko JJ, Doran AR, Konicki PE, Potter WZ, Pickar D (1993) Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics. Arch Gen Psychiatry 50:606–614

    CAS  PubMed  Google Scholar 

  • Hyman SE, Nestler EJ (1993) The molecular foundations of psychiatry. American Psychiatric Press, Washington

    Google Scholar 

  • Kim JS, Kornhuber HH, Schmid-Burgk W, Holzmüller B (1980) Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 20:379–382

    Article  CAS  PubMed  Google Scholar 

  • Kornhuber J, Beckmann H, Riederer P (1990) Das dopaminergglutamaterge Gleichgewicht unter dem Aspekt von schizophrener Plus-und Minussymptomatik. In: Möller HJ, Pelzer E (Hrsg) Neuere Ansätze zur Diagnostik und Therapie schizophrener Minussymptomatik. Springer, Berlin Heidelberg New York Tokyo, S 119–126

    Google Scholar 

  • Lesch KP, Bengel D, Heils A et al. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527–1531

    Article  CAS  PubMed  Google Scholar 

  • Mann JJ, Brent DA, Arango V (2001) The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology 24:467–472

    Article  CAS  PubMed  Google Scholar 

  • Murphy DL, Mueller EA, Garrick NA, Aulakh CS (1986) Use of serotonergic agents in the clinical assessment of central serotonin function. J Clin Psychiatry 47:9–15

    CAS  PubMed  Google Scholar 

  • Reinikainen KJ, Soininen H, Riekkinen PJ (1990) Neurotransmitter changes in Alzheimer’s disease: implications to diagnostics and therapy. J Neruosci Res 27:576–586

    CAS  Google Scholar 

  • Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509–522

    CAS  PubMed  Google Scholar 

  • Sherman AD, Davidson AT, Baruah S, Hegwood TS, Waziri R (1991) Evidence of glutamatergic deficiency in schizophrenia. Neurosci Lett 121:77–80

    Article  CAS  PubMed  Google Scholar 

  • Suhara I, Okuba Y, Yasawa F et al. (2002) Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia. Arch Gen Psychiatry 59:25–30

    CAS  PubMed  Google Scholar 

  • Thome J, Riederer P (1995) Neurobiologie der Aggressivität. In: Nissen G (Hrsg) Aggressivität und Gewalt. Prävention und Therapie. Huber, Bern Göttingen Toronto Seattle, S 29–38

    Google Scholar 

  • Thome J, Foley P, Riederer P (1998) Neurotrophic factors and the maldevelopmental hypothesis of schizophrenic psychoses. J Neural Transm 105:85–100

    Article  CAS  PubMed  Google Scholar 

  • Tsai G, Passani LA, Slusher BS, Carter R, Baer L, Kleinman JE, Coyle JT (1995) Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 52:829–836

    CAS  PubMed  Google Scholar 

  • Zilles K, Rehkäprmper G (1994) Funktionelle Neuroanatomie, 2. Aufl. Springer, Berlin Hiedelberg New York Tokyo

    Google Scholar 

Download references

Authors
  1. J. Thome
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Riederer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Psychiatrie und Psychotherapie, Klinikum der Ludwig-Maximilians-Universität München, Nußbaumstraße 7, 80336, München

    Hans-Jürgen Möller  & Hans-Peter Kapfhammer  & 

  2. Bezirksklinikum Gabersee, Fachkrankenhaus für Psychiatrie Psychotherapie und Neurologie, Gabersee 7, 83512, Wasserburg a. Inn

    Gerd Laux

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Thome, J., Riederer, P. (2003). Störungen der Neurotransmission als Grundlage psychiatrischer Erkrankungen. In: Möller, HJ., Laux, G., Kapfhammer, HP. (eds) Psychiatrie und Psychotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27386-7_6

Download citation

  • DOI: https://doi.org/10.1007/3-540-27386-7_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-25074-6

  • Online ISBN: 978-3-540-27386-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation